Fig. 3 | Scientific Reports

Fig. 3

From: Integrative bioinformatics analysis identifies METTL1 as a regulator of immune infiltration and prognosis in breast cancer

Fig. 3

Correlation of METTL1 expression with the prognosis of breast invasive carcinoma patients. (a–c) The correlation between overall survival (a), disease specific survival (b), and disease free survival (c) of BRCA patients and METTL1 expression were analyzed by survival and survminer packages. (d–e) The univariate (d) and multivariate (e) Cox regression analysis was performed to evaluate the predictive value of METTL1 expression and clinical variables (age, cancer stage, tumor size, metastasis, lymph node involvement) for overall survival in BRCA patients. BRCA, breast invasive carcinoma.

Back to article page